EXOTHERA, société anonyme – Trademark Portfolio

Entity Type: 99

EXOTHERA, société anonyme holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 40 (Treatment & Processing) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include EXOSCAN, EXOREADY, and EXOTHERA.

Zoning de Jumet,

Allée Centrale 52 B-6040 Charleroi

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EXOREADY
EXOREADY
Registered 2022
EXOSCAN
EXOSCAN
Registered 2022
EXOTHERA
EXOTHERA
Registered 2020

Trademark Classifications

EXOTHERA, société anonyme's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

40
Treatment & Processing (3 filings)

Treatment of materials

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does EXOTHERA, société anonyme have?

EXOTHERA, société anonyme has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does EXOTHERA, société anonyme file in?

EXOTHERA, société anonyme files trademarks across 2 Nice Classification classes. The most active classes are Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). Class 40 covers treatment of materials.

What are EXOTHERA, société anonyme's most well-known trademarks?

EXOTHERA, société anonyme's registered trademark portfolio includes well-known marks such as EXOSCAN, EXOREADY, and EXOTHERA. These are among 3 currently registered trademarks in the portfolio.

What is EXOTHERA, société anonyme's trademark registration success rate?

EXOTHERA, société anonyme has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.